JP Stock MarketDetailed Quotes

4503 Astellas Pharma

Watchlist
  • 1689.0
  • +25.0+1.50%
20min DelayMarket Closed Jul 26 15:00 JST
3.06TMarket Cap178.35P/E (Static)

Astellas Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Astellas Pharma Earnings Date

Currency: JPY

Period

Q1 FY2025 Estimates

Aug 1, 2024

Revenue(YoY)

411.42B

+9.71%
EPS(YoY)

10.20

-44.74%
Analyst Rating

Buy

Jul 18, 2024

Astellas Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 425.180B--
Aug 1, 20242025/Q1-- / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--
Nov 1, 20232024/Q2392.148B / 355.602B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 425.180B--
Aug 1, 20242025/Q1-- / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--
Nov 1, 20232024/Q2392.148B / 355.602B--

Unlock Free Earnings Estimates

Astellas Pharma Earnings Reports

  • Astellas Pharma: Extraordinary Report

    Jul 1 01:47 ET

  • Astellas Pharma: Confirmation letter

    Jun 20 03:22 ET

  • Astellas Pharma: Securities Report - 19th Period (April 1, 2023 - March 31, 2024)

    Jun 20 03:19 ET

  • Astellas Pharma: Financial results briefing materials for the fiscal year ending March 2024

    Apr 25 02:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 18, 2024

    Buy

    • Strong Buy

      37.50%

    • Buy

      12.50%

    • Hold

      43.75%

    • Underperform

      6.25%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg